Category: Latest News

Viking Holdings Ltd (NYSE:VIK) shares rose nearly 3% in premarket trading after the cruise operator delivered fourth-quarter results that topped Wall Street expectations, driven by higher capacity and strong passenger demand. Adjusted earnings per share came in at $0.67, surpassing the analyst consensus of $0.48 by $0.19. Quarterly revenue climbed 27.8% year over year to…

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) posted better-than-expected fourth-quarter results on Tuesday, but shares declined more than 3% in premarket trading as investors assessed the company’s regulatory and commercialization outlook. The biotech reported a quarterly loss of $0.30 per share, narrower than the analyst consensus estimate of a $0.34 loss. Revenue was not disclosed for the quarter.…

Micron Technology, Inc. (NASDAQ:MU) announced it has begun shipping customer samples of what it calls the world’s first 256GB SOCAMM2 low-power DRAM module, marking a new capacity milestone for data center memory. The module is powered by the industry’s first monolithic 32Gb LPDDR5X die design and is aimed at next-generation AI and high-performance computing (HPC)…

Harrow (NASDAQ:HROW) said Tuesday that the U.S. Food and Drug Administration has cleared its Investigational New Drug (IND) application, paving the way for a Phase 3 clinical trial of TRIESENCE® (preservative-free triamcinolone acetonide injectable suspension) 40 mg/mL in patients undergoing cataract surgery. The late-stage study will evaluate TRIESENCE for the treatment of ocular inflammation and…

Versus Systems (NASDAQ:VS) announced March 3, 2026 that it has renewed its partnership with Major League Baseball’s Texas Rangers, extending the use of its Filter Fan Cam technology at Globe Life Field through the 2026 season. The renewal builds on a five-year collaboration and strengthens Versus’ footprint in the live sports entertainment space. By continuing…

Antelope Enterprise Holdings (NASDAQ:AEHL) said on March 3, 2026 that its board has authorized a 1-for-6 reverse stock split of the company’s Class A ordinary shares. As a result of the consolidation, the number of shares outstanding will decrease from 7,344,694 to approximately 1,224,116. The company’s shares will continue trading on the Nasdaq Capital Market…

Propanc Biopharma (NASDAQ:PPCB) is drawing attention to the therapeutic promise of its lead candidate, PRP, an investigational proenzyme treatment aimed at tackling metastatic cancer arising from solid tumors—particularly aggressive, poorly differentiated forms associated with poor patient outcomes. Pancreatic cancer remains among the most lethal malignancies, with a five-year survival rate of just 13%, compared to…

Mobix Labs, Inc. (NASDAQ:MOBX) said Tuesday it has received a production purchase order for components used in the U.S. Navy’s Tomahawk cruise missile program, underscoring its role as a supplier to active defense platforms. The order covers high-reliability filtering components designed to reduce electromagnetic interference within the missile’s onboard electronic systems. According to the company,…

Ziff Davis (NASDAQ:ZD) has reached an agreement to sell its Connectivity business to Accenture in a cash transaction valued at $1.2 billion, marking another step in the company’s multi-year portfolio reshaping strategy. The divested unit includes well-known assets such as Ookla’s Speedtest platform and outage-monitoring service Downdetector, along with Ekahau and RootMetrics. Following the sale,…

Theravance Biopharma (NASDAQ:TBPH) said March 3, 2026 that its Phase 3 CYPRESS study evaluating ampreloxetine in patients with symptomatic neurogenic orthostatic hypotension (nOH) linked to multiple system atrophy did not achieve its primary endpoint, prompting the company to discontinue the program. The biotech firm said it will carry out additional data analyses solely to determine…